Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study

• Conditions: Covid19

• Registration Number: NCT04872699
• Lead Sponsor: Centre Hospitalier Sud Essonne

Brief Summary

The aim of this study is to evaluate the prevalence of COVID-19 among the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), and the factors that are likely to influence this prevalence.

Detailed Description

Among people exposed to the COVID-19 (SARS-COV-2) pandemic, elderly people are considered as particularly vulnerable, especially those living in nursing homes or hospitalized. Furthermore, facilities / accommodations are registered among the main locations of COVID-19 clusters.

These observations have led the French government to establish specific protection measures and survey dependent care facilities for the elderly and long-term care units in the hospital.

With these new standards established, a long-term study of all the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), can provide additional knowledge on COVID-19.

Study Timeline

• Study Start: 2021-04-22
• Status Verified: 2021-05
• Study First Submitted: 2021-05-02
• Study First Submitted QC: 2021-05-02
• Last Update Submitted: 2021-05-02
• Study First Posted: 2021-05-04
• Last Update Posted: 2021-05-04
• Primary Completion: 2021-05-31
• Study Completion: 2022-05-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• residents of the dependant care facility for the elderly
• inpatients of the long-term care unit
• from march, 2020 to december, 2021

Exclusion Criteria

• opposition to participate in this study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
General prevalence of COVID-19	Through the study completion, an average of 12 months	measures the prevalence of COVID-19 among the residents and geriatric inpatients, defined as resident and patients with positive serologic or RT-PCR test

Secondary Outcome Measures

Name	Time	Method
Number of symptomatic residents/inpatients	Through study completion, an average of 12 months	Positive RT-PCR test or serologic test with symptoms
Number of residents/inpatients vaccinated against COVID-19	Through study completion, an average of 12 months	Positive RT-PCR test or serologic test and vaccinated with any authorized vaccine
Number of residents/inpatients infected with COVID-19 and deceased	Through study completion, an average of 12 months	Positive RT-PCR test or serologic test and deceased
Influencing factors of the prevalence of COVID-19 among residents/inpatients	Through study completion, an average of 12 months	* age; * sex; * comorbidities; * the context of the infection with COVID-19; * vaccinated or not
Number of asymptomatic residents/inpatients	Through study completion, an average of 12 months	* no RT-PCR test or negative RT-PCR test and positive serologic test,; * positive RT PCR and no symptoms.
Number of residents/inpatients infected with COVID-19 and hospitalized in a critical care unit	Through study completion, an average of 12 months	Positive RT-PCR test or serologic test and hospitalization in critical care unit
Number of residents/inpatients with severe form of COVID-19 which led to an hospitalization	Through study completion, an average of 12 months	Positive RT-PCR test or serologic test and hospitalization

Trial Locations

Locations (1)

Centre Hospitalier Sud Essonne; 🇫🇷 Étampes, Essonne, France